menu search

Pantheon vision raises $2.5 million in seed funding to launch development of bioengineered corneal implant

The medical device startup is focused on addressing significant unmet needs of patients suffering from corneal blindness around the world BALTIMORE, M...

November 2, 2023, 6:06 pm

Spyglass pharma initiates phase i/ii clinical trial of its intraocular drug delivery platform

Phase I/II trial initiated to investigate innovative SpyGlass platform for the long-term delivery of bimatoprost in patients with glaucoma and visuall...

October 31, 2023, 11:00 am

Iridex to report third quarter financial results on november 14, 2023

MOUNTAIN VIEW, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ...

October 26, 2023, 4:22 pm

Eyenovia to present data on preservative-free microbial integrity of the optejet®

In rigorous testing, the Optejet remained contaminant-free when subjected to a microbial load that exceeds typical environmental conditions Presentati...

October 9, 2023, 11:00 am

Ocuphire pharma to present at euretina and retina society conferences in october

Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy FARMINGTON HILLS, Mich., Oct. 06, 2023 (GLOBE NEWSWIRE) �...

October 6, 2023, 12:00 pm

Outlook therapeutics® requests type a meeting with fda

ISELIN, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approv...

September 29, 2023, 12:05 pm

Week in review: everest acquires novel autoimmune therapy in $132 million agreement

Shanghai Everest Medicines acquired China/Asian rights to a novel therapy for autoimmune diseases from Kezar Life Sciences of South San Francisco in a...

September 24, 2023, 10:33 pm

Outlook therapeutics® to present at the 2023 cantor fitzgerald global healthcare conference

Live video webcast panel presentation on Tuesday, September 26th at 1:35 PM ET ISELIN, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics,...

September 21, 2023, 12:05 pm

Annexon biosciences to participate in the 2023 cantor global healthcare conference

BRISBANE, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class o...

September 19, 2023, 6:30 am

Walgreens and cvs among companies warned by fda against marketing unapproved eye products

The US Food and Drug Administration (FDA) has issued warning letters to eight companies including Walgreens Boots Alliance Inc (NASDAQ:WBA) and CVS He...

September 13, 2023, 8:56 am

Fda warns cvs, walgreens about marketing of unapproved eye products

The U.S. Food and Drug Administration this week warned CVS Health Corp. CVS, +2.78%, Walgreens Boots Alliance Inc. WBA, +3.17% and several smaller con...

September 12, 2023, 11:31 am

Fda issues warning letter to cvs, walgreens and others for selling unapproved eye products

The U.S. Food and Drug Administration on Tuesday said it has issued warning letters to eight companies, including pharmacy giants CVS Health Corp and ...

September 12, 2023, 11:06 am

Tarsus pharmaceuticals: worthy of a small bet

Tarsus Pharmaceuticals has received FDA approval for its lotilaner ophthalmic solution for the treatmen...

September 4, 2023, 8:36 am

Eyenovia: it is now time to see positive results in their marketing efforts

Eyenovia has obtained the first required state pharmacy license from New York, allowing them to obtain the first commercial sale of their drug candida...

August 28, 2023, 5:08 pm

Onl therapeutics completes enrollment in phase 2 study of first-in-class fas-inhibitor in patients with macula-off rhegmatogenous retinal detachment

More than 135 patients recruited in four months for Phase 2 study of a single intravitreal (IVT) injection of ONL1204 ...

August 28, 2023, 11:00 am

Eyenovia announces $12 million registered direct offering

NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic...

August 24, 2023, 10:47 pm

Rvl pharmaceuticals plc announces $5 million registered direct offering priced at-the-market under nasdaq rules

BRIDGEWATER, N.J., Aug. 16, 2023 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceuti...

August 16, 2023, 12:00 pm

Eyenovia acquires u.s. commercial rights to app13007 (clobetasol propionate ophthalmic nanosuspension, 0.05%) from formosa pharmaceuticals

APP13007, if approved, may have an advantageous profile in dosing frequency and side effects while reducing the inflammation and pain associated with ...

August 16, 2023, 10:00 am

Outlook therapeutics® to present at the btig virtual biotechnology conference 2023

ISELIN, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA appr...

August 1, 2023, 8:45 am

Addressing vision challenges: ophthalmic injectable market is estimated to grow at a cagr of 4.9% to cross us$ 30 billion by 2033 | future market insights, inc.

The growing prevalence of eye ailments and diseases is driving the Global ophthalmic injectable market....

July 27, 2023, 4:30 pm


Search within

Pages Search Results: